Online ISSN: 2577-5669
-
Development of Telmisartan 40 mg Tablets with Improved Bioavailability Using Solid Dispersion Technique
Volume 17 | Issue 1
-
Design and optimization of Glibenclamide -nanoemulsion Technology for Enhanced Drug Delivery
Volume 17 | Issue 1
-
Formulation and evaluation of nano emulsion of aceclofenac (100mg) for enhanced solubility and dissolution rate
Volume 17 | Issue 1
-
Development of Controlled Release Matrix Tablets using Natural Polymers
Volume 17 | Issue 1
-
Evolution of Drug Regulatory Guidelines in the Era of Globalization
Volume 17 | Issue 1
Screening for Non-Alcoholic Fatty Liver Disease in Patients with Metabolic Syndrome in a Community Setting: Correlation with Clinical and Biochemical Parameters
Main Article Content
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome (MetS) and is increasingly prevalent in the South Asian population. Limited data exist on NAFLD prevalence and its biochemical correlates in rural community
